Orion Portfolio Solutions LLC Trims Position in Option Care Health, Inc. (NASDAQ:OPCH)

Orion Portfolio Solutions LLC reduced its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 4.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,029 shares of the company’s stock after selling 1,203 shares during the period. Orion Portfolio Solutions LLC’s holdings in Option Care Health were worth $627,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp purchased a new stake in Option Care Health in the fourth quarter valued at $26,000. UMB Bank n.a. boosted its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after buying an additional 346 shares during the last quarter. Signaturefd LLC grew its holdings in Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after acquiring an additional 1,005 shares during the period. Blue Trust Inc. raised its position in Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock valued at $109,000 after acquiring an additional 681 shares in the last quarter. Finally, Venturi Wealth Management LLC raised its position in Option Care Health by 2,621.3% during the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock valued at $110,000 after acquiring an additional 4,561 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Price Performance

NASDAQ:OPCH opened at $32.87 on Tuesday. The stock has a 50 day moving average of $33.00 and a two-hundred day moving average of $28.50. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The firm has a market cap of $5.40 billion, a P/E ratio of 27.62, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $26.00 to $33.00 in a report on Monday, January 13th. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. JPMorgan Chase & Co. increased their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. Barrington Research lifted their price target on Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Finally, Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and upped their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Option Care Health has a consensus rating of “Moderate Buy” and an average price target of $33.00.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.64% of the stock is owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.